Identified by CAS Number 89030-95-5, GHK-Cu is widely referenced in peptide research literature due to its characterized copper coordination chemistry, defined molecular structure, and reproducible analytical profile
Press the plunger (or injection button) to deliver the medication
Potential downsides include mild side effects such as headaches, injection site irritation, or temporary appetite changes
Patients with pre-existing cardiac arrhythmias or significant cardiovascular disease should be monitored appropriately when initiating GLP-1 therapy, though these conditions are not absolute contraindications
The medication also slows down the emptying of the stomach, which can help to reduce food intake
Very dark skin may take up to 12 months to see visible results